Paul R Michl
Examiner (ID: 9867)
Most Active Art Unit | 1505 |
Art Unit(s) | 1511, 3502, 1503, 2899, 1714, 1201, 1505, 1506, 3305, 1509 |
Total Applications | 2093 |
Issued Applications | 1688 |
Pending Applications | 51 |
Abandoned Applications | 353 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 558320
[patent_doc_number] => 07157425
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-02
[patent_title] => 'Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders'
[patent_app_type] => utility
[patent_app_number] => 10/099574
[patent_app_country] => US
[patent_app_date] => 2002-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 23
[patent_no_of_words] => 37034
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 284
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/157/07157425.pdf
[firstpage_image] =>[orig_patent_app_number] => 10099574
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/099574 | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders | Mar 14, 2002 | Issued |
Array
(
[id] => 6721546
[patent_doc_number] => 20030055236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'Secreted protein HKABT24'
[patent_app_type] => new
[patent_app_number] => 10/097065
[patent_app_country] => US
[patent_app_date] => 2002-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 112873
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20030055236.pdf
[firstpage_image] =>[orig_patent_app_number] => 10097065
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/097065 | Secreted protein HKABT24 | Mar 13, 2002 | Abandoned |
Array
(
[id] => 6307847
[patent_doc_number] => 20020094956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-18
[patent_title] => 'Use of alpha1beta1 integrin receptor inhibitors and TGF-beta1 inhibitors in the treatment of kidney disease'
[patent_app_type] => new
[patent_app_number] => 10/099573
[patent_app_country] => US
[patent_app_date] => 2002-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 21811
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20020094956.pdf
[firstpage_image] =>[orig_patent_app_number] => 10099573
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/099573 | Use of alpha1beta1 integrin receptor inhibitors and TGF-beta1 inhibitors in the treatment of kidney disease | Mar 11, 2002 | Abandoned |
Array
(
[id] => 6553326
[patent_doc_number] => 20020138203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => 'Method and system for designing proteins and protein backbone configurations'
[patent_app_type] => new
[patent_app_number] => 10/093109
[patent_app_country] => US
[patent_app_date] => 2002-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4446
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20020138203.pdf
[firstpage_image] =>[orig_patent_app_number] => 10093109
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/093109 | Method and system for designing proteins and protein backbone configurations | Mar 6, 2002 | Abandoned |
Array
(
[id] => 5860597
[patent_doc_number] => 20020123846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-05
[patent_title] => 'Method and system for designing proteins and protein backbone configurations'
[patent_app_type] => new
[patent_app_number] => 10/093108
[patent_app_country] => US
[patent_app_date] => 2002-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4453
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20020123846.pdf
[firstpage_image] =>[orig_patent_app_number] => 10093108
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/093108 | Method and system for designing proteins and protein backbone configurations | Mar 6, 2002 | Abandoned |
Array
(
[id] => 6687626
[patent_doc_number] => 20030031350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'Methods for large scale protein matching'
[patent_app_type] => new
[patent_app_number] => 10/087541
[patent_app_country] => US
[patent_app_date] => 2002-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5994
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20030031350.pdf
[firstpage_image] =>[orig_patent_app_number] => 10087541
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/087541 | Methods for large scale protein matching | Feb 28, 2002 | Abandoned |
10/084615 | Platelet production promoting agent | Feb 27, 2002 | Abandoned |
Array
(
[id] => 7617002
[patent_doc_number] => 06946439
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-09-20
[patent_title] => 'Compositions and methods for inhibiting cellular proliferation comprising TFPI fragments'
[patent_app_type] => utility
[patent_app_number] => 10/086176
[patent_app_country] => US
[patent_app_date] => 2002-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 10841
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/946/06946439.pdf
[firstpage_image] =>[orig_patent_app_number] => 10086176
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/086176 | Compositions and methods for inhibiting cellular proliferation comprising TFPI fragments | Feb 27, 2002 | Issued |
Array
(
[id] => 6646757
[patent_doc_number] => 20030104408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Method and device for assembling nucleic acid base sequences'
[patent_app_type] => new
[patent_app_number] => 10/083338
[patent_app_country] => US
[patent_app_date] => 2002-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 11387
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20030104408.pdf
[firstpage_image] =>[orig_patent_app_number] => 10083338
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/083338 | Method and device for assembling nucleic acid base sequences | Feb 26, 2002 | Issued |
Array
(
[id] => 5922900
[patent_doc_number] => 20020115594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-22
[patent_title] => 'Peptide antagonists at glutamate and NMDA receptors'
[patent_app_type] => new
[patent_app_number] => 10/087011
[patent_app_country] => US
[patent_app_date] => 2002-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6964
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20020115594.pdf
[firstpage_image] =>[orig_patent_app_number] => 10087011
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/087011 | Peptide antagonists at glutamate and NMDA receptors | Feb 25, 2002 | Abandoned |
Array
(
[id] => 6787615
[patent_doc_number] => 20030138854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-24
[patent_title] => 'Method for determining BAGE expression'
[patent_app_type] => new
[patent_app_number] => 10/081108
[patent_app_country] => US
[patent_app_date] => 2002-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7456
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20030138854.pdf
[firstpage_image] =>[orig_patent_app_number] => 10081108
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/081108 | Method for determining BAGE expression | Feb 19, 2002 | Abandoned |
Array
(
[id] => 796555
[patent_doc_number] => 07430476
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-30
[patent_title] => 'Method for identification of t-cell epitopes and use for preparing molecules with reduced immunogenicity'
[patent_app_type] => utility
[patent_app_number] => 10/468496
[patent_app_country] => US
[patent_app_date] => 2002-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 35533
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 219
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/430/07430476.pdf
[firstpage_image] =>[orig_patent_app_number] => 10468496
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/468496 | Method for identification of t-cell epitopes and use for preparing molecules with reduced immunogenicity | Feb 17, 2002 | Issued |
Array
(
[id] => 6419429
[patent_doc_number] => 20020183937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-05
[patent_title] => 'Method for the generation of proteins with new enzymatic function'
[patent_app_type] => new
[patent_app_number] => 10/074679
[patent_app_country] => US
[patent_app_date] => 2002-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 24834
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20020183937.pdf
[firstpage_image] =>[orig_patent_app_number] => 10074679
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/074679 | Method for the generation of proteins with new enzymatic function | Feb 10, 2002 | Abandoned |
Array
(
[id] => 6844586
[patent_doc_number] => 20030149933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'Graphical design of chemical discovery processes'
[patent_app_type] => new
[patent_app_number] => 10/061960
[patent_app_country] => US
[patent_app_date] => 2002-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 8311
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 211
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20030149933.pdf
[firstpage_image] =>[orig_patent_app_number] => 10061960
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/061960 | Graphical design of chemical discovery processes | Jan 31, 2002 | Abandoned |
Array
(
[id] => 6721530
[patent_doc_number] => 20030055220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'Protein-protein interactions between Shigella flexneri polypeptides and mammalian polypeptides'
[patent_app_type] => new
[patent_app_number] => 10/043487
[patent_app_country] => US
[patent_app_date] => 2002-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 26996
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20030055220.pdf
[firstpage_image] =>[orig_patent_app_number] => 10043487
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/043487 | Protein-protein interactions between Shigella flexneri polypeptides and mammalian polypeptides | Jan 10, 2002 | Abandoned |
Array
(
[id] => 6048889
[patent_doc_number] => 20020169264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-14
[patent_title] => 'Polymers incorporating peptides'
[patent_app_type] => new
[patent_app_number] => 10/044034
[patent_app_country] => US
[patent_app_date] => 2002-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 16339
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20020169264.pdf
[firstpage_image] =>[orig_patent_app_number] => 10044034
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/044034 | Polymers incorporating peptides | Jan 10, 2002 | Abandoned |
Array
(
[id] => 6710970
[patent_doc_number] => 20030170719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'NF-kappa B activating gene'
[patent_app_type] => new
[patent_app_number] => 10/042211
[patent_app_country] => US
[patent_app_date] => 2002-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 20523
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170719.pdf
[firstpage_image] =>[orig_patent_app_number] => 10042211
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/042211 | NF-kappa B activating gene | Jan 6, 2002 | Abandoned |
Array
(
[id] => 6745102
[patent_doc_number] => 20030022285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => 'Protein design automation for designing protein libraries with altered immunogenicity'
[patent_app_type] => new
[patent_app_number] => 10/039170
[patent_app_country] => US
[patent_app_date] => 2002-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 32124
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20030022285.pdf
[firstpage_image] =>[orig_patent_app_number] => 10039170
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/039170 | Protein design automation for designing protein libraries with altered immunogenicity | Jan 3, 2002 | Abandoned |
Array
(
[id] => 6715872
[patent_doc_number] => 20030027220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-06
[patent_title] => 'Chemical modification'
[patent_app_type] => new
[patent_app_number] => 10/037212
[patent_app_country] => US
[patent_app_date] => 2002-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 28325
[patent_no_of_claims] => 88
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20030027220.pdf
[firstpage_image] =>[orig_patent_app_number] => 10037212
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/037212 | Chemical modification | Jan 3, 2002 | Abandoned |
Array
(
[id] => 6730714
[patent_doc_number] => 20030186904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Keratinocyte growth factor-2'
[patent_app_type] => new
[patent_app_number] => 10/035212
[patent_app_country] => US
[patent_app_date] => 2002-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 64
[patent_figures_cnt] => 64
[patent_no_of_words] => 144684
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20030186904.pdf
[firstpage_image] =>[orig_patent_app_number] => 10035212
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/035212 | Keratinocyte growth factor-2 | Jan 3, 2002 | Abandoned |